The majority of specimens to be sent to CMML may be categorized as Category B, Biological Substance (Un number UN3373).For further information on how to properly categorize and prepare specimens please refer to the WHO Guidance on Regulations for the Transport of Infectious Substances 2019 – 2020. To download, please click on the link below - https://apps.who.int/iris/bitstream/handle/10665/325884/WHO-WHE-CPI-2019.20-eng.pdf?ua=1
Shippers of infectious substances shall ensure that packages are prepared utilizing the Triple Packaging System. This packaging system is used for the transportation of all infectious substances in such a manner that they reach their destination in good condition and present no hazard to persons or animals during transport.
Infectious substances which fall under Category A can only be transported in packaging which meets the UN Class 6.2 Specifications and in accordance with Packaging Instruction (PI) 620 of the IATA DGR.
TABLE 2: Requirements for Packaging and Shipping Category A Substances
Markings –
Labels –
Must be signed by the shipper
Example of the packaging and labelling of a Category A, Infectious Substance (Reference Guidance on regulations for the transport of infectious substances 2017-2018. Geneva, Switzerland: World Health Organization; 2017)
Most specimens (primary specimens) sent to CMML can be categorized with the Proper Shipping Name Category B, Biological Substance. The shipper must comply fully with the requirements of Packaging Instruction PI 650.
TABLE 3: Requirements for Packaging and Shipping Category B Substances
Note: Dangerous Goods Declaration Form is not required, even when shipping with Dry Ice
Figure 2: Example of Triple Packaging System for the packaging and labelling of Category B, Infectious Substance (Reference Guidance on regulations for the transport of infectious substances 2017-2018. Geneva, Switzerland: World Health Organization; 2017)
Other: Shipping Exempt Substances
An element of professional judgment is required to determine if a substance is exempt. That judgment should be based on the known medical history, symptoms and individual circumstances of the source, human or animal, and endemic local conditions.
TABLE 4: Requirements for Packaging and Shipping Exempt Substances
Copyright 2022 by The Caribbean Public Health Agency